Percutaneous management of renal pelvic tumors: A treatment option in selected cases

A. D. Smith, Eduardo Orihuela, A. R. Crowley

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Nine patients with renal pelvic transitional cell carcinomas were selected for treatment with percutaneous resection because of a solitary kidney (3), bilateral synchronous disease (1), renal insufficiency (1), poor surgical risk (2) or preoperative evidence of a single, low grade, superficial tumor (2). Eight patients underwent second-look procedures 2 to 28 days postoperatively, at which time 6 received neodymium:YAG laser irradiation. Supplemental intracavitary therapy through the nephrostomy tube was given in 6 patients (mitomycin C in 1 and bacillus Calmette-Guerin in 5). Of those patients 2 had third-look procedures. Five patients remain free of recurrence with a followup of 3 to 28 months (mean 9.5 months). In the other 4 patients there was recurrent disease in the renal pelvis (3) or reappearance of positive cytology studies (1) 4 to 5 months postoperatively. Extrarenal tumor recurrence was not observed. Percutaneous surgery provided adequate information to assess tumor architecture, grade, invasiveness and multifocality, and the presence of contiguous mucosal abnormalities, which, along with positive cytology and a history of or concurrent tumors in other segments of the urinary tract, increased the likelihood of tumor recurrence. Second-look procedures appeared to be useful to assess the effectiveness of the initial procedure and to remove any residual disease. Our results suggest that percutaneous surgery can provide results similar to those of an open conservative operation, although further investigation is needed to determine the ultimate place of this technique.

Original languageEnglish (US)
Pages (from-to)852-856
Number of pages5
JournalJournal of Urology
Volume137
Issue number5
StatePublished - 1987
Externally publishedYes

Fingerprint

Kidney
Neoplasms
Recurrence
Cell Biology
Therapeutics
Neodymium
Kidney Pelvis
Transitional Cell Carcinoma
Solid-State Lasers
Mitomycin
Mycobacterium bovis
Urinary Tract
Renal Insufficiency

ASJC Scopus subject areas

  • Urology

Cite this

Smith, A. D., Orihuela, E., & Crowley, A. R. (1987). Percutaneous management of renal pelvic tumors: A treatment option in selected cases. Journal of Urology, 137(5), 852-856.

Percutaneous management of renal pelvic tumors : A treatment option in selected cases. / Smith, A. D.; Orihuela, Eduardo; Crowley, A. R.

In: Journal of Urology, Vol. 137, No. 5, 1987, p. 852-856.

Research output: Contribution to journalArticle

Smith, AD, Orihuela, E & Crowley, AR 1987, 'Percutaneous management of renal pelvic tumors: A treatment option in selected cases', Journal of Urology, vol. 137, no. 5, pp. 852-856.
Smith, A. D. ; Orihuela, Eduardo ; Crowley, A. R. / Percutaneous management of renal pelvic tumors : A treatment option in selected cases. In: Journal of Urology. 1987 ; Vol. 137, No. 5. pp. 852-856.
@article{2931f846e6cd420dba57aa3ddbca22ce,
title = "Percutaneous management of renal pelvic tumors: A treatment option in selected cases",
abstract = "Nine patients with renal pelvic transitional cell carcinomas were selected for treatment with percutaneous resection because of a solitary kidney (3), bilateral synchronous disease (1), renal insufficiency (1), poor surgical risk (2) or preoperative evidence of a single, low grade, superficial tumor (2). Eight patients underwent second-look procedures 2 to 28 days postoperatively, at which time 6 received neodymium:YAG laser irradiation. Supplemental intracavitary therapy through the nephrostomy tube was given in 6 patients (mitomycin C in 1 and bacillus Calmette-Guerin in 5). Of those patients 2 had third-look procedures. Five patients remain free of recurrence with a followup of 3 to 28 months (mean 9.5 months). In the other 4 patients there was recurrent disease in the renal pelvis (3) or reappearance of positive cytology studies (1) 4 to 5 months postoperatively. Extrarenal tumor recurrence was not observed. Percutaneous surgery provided adequate information to assess tumor architecture, grade, invasiveness and multifocality, and the presence of contiguous mucosal abnormalities, which, along with positive cytology and a history of or concurrent tumors in other segments of the urinary tract, increased the likelihood of tumor recurrence. Second-look procedures appeared to be useful to assess the effectiveness of the initial procedure and to remove any residual disease. Our results suggest that percutaneous surgery can provide results similar to those of an open conservative operation, although further investigation is needed to determine the ultimate place of this technique.",
author = "Smith, {A. D.} and Eduardo Orihuela and Crowley, {A. R.}",
year = "1987",
language = "English (US)",
volume = "137",
pages = "852--856",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Percutaneous management of renal pelvic tumors

T2 - A treatment option in selected cases

AU - Smith, A. D.

AU - Orihuela, Eduardo

AU - Crowley, A. R.

PY - 1987

Y1 - 1987

N2 - Nine patients with renal pelvic transitional cell carcinomas were selected for treatment with percutaneous resection because of a solitary kidney (3), bilateral synchronous disease (1), renal insufficiency (1), poor surgical risk (2) or preoperative evidence of a single, low grade, superficial tumor (2). Eight patients underwent second-look procedures 2 to 28 days postoperatively, at which time 6 received neodymium:YAG laser irradiation. Supplemental intracavitary therapy through the nephrostomy tube was given in 6 patients (mitomycin C in 1 and bacillus Calmette-Guerin in 5). Of those patients 2 had third-look procedures. Five patients remain free of recurrence with a followup of 3 to 28 months (mean 9.5 months). In the other 4 patients there was recurrent disease in the renal pelvis (3) or reappearance of positive cytology studies (1) 4 to 5 months postoperatively. Extrarenal tumor recurrence was not observed. Percutaneous surgery provided adequate information to assess tumor architecture, grade, invasiveness and multifocality, and the presence of contiguous mucosal abnormalities, which, along with positive cytology and a history of or concurrent tumors in other segments of the urinary tract, increased the likelihood of tumor recurrence. Second-look procedures appeared to be useful to assess the effectiveness of the initial procedure and to remove any residual disease. Our results suggest that percutaneous surgery can provide results similar to those of an open conservative operation, although further investigation is needed to determine the ultimate place of this technique.

AB - Nine patients with renal pelvic transitional cell carcinomas were selected for treatment with percutaneous resection because of a solitary kidney (3), bilateral synchronous disease (1), renal insufficiency (1), poor surgical risk (2) or preoperative evidence of a single, low grade, superficial tumor (2). Eight patients underwent second-look procedures 2 to 28 days postoperatively, at which time 6 received neodymium:YAG laser irradiation. Supplemental intracavitary therapy through the nephrostomy tube was given in 6 patients (mitomycin C in 1 and bacillus Calmette-Guerin in 5). Of those patients 2 had third-look procedures. Five patients remain free of recurrence with a followup of 3 to 28 months (mean 9.5 months). In the other 4 patients there was recurrent disease in the renal pelvis (3) or reappearance of positive cytology studies (1) 4 to 5 months postoperatively. Extrarenal tumor recurrence was not observed. Percutaneous surgery provided adequate information to assess tumor architecture, grade, invasiveness and multifocality, and the presence of contiguous mucosal abnormalities, which, along with positive cytology and a history of or concurrent tumors in other segments of the urinary tract, increased the likelihood of tumor recurrence. Second-look procedures appeared to be useful to assess the effectiveness of the initial procedure and to remove any residual disease. Our results suggest that percutaneous surgery can provide results similar to those of an open conservative operation, although further investigation is needed to determine the ultimate place of this technique.

UR - http://www.scopus.com/inward/record.url?scp=0023238751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023238751&partnerID=8YFLogxK

M3 - Article

C2 - 3106652

AN - SCOPUS:0023238751

VL - 137

SP - 852

EP - 856

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -